This month we've added five new studies to the Best Practice Database. Three of the five new studies deal with cardiovascular product launch factors, the fourth one addresses optimization of the professional and trade relations function and the last study evaluates the use of exclusive vendor partnerships.

Two of the studies on cardiovascular product launches present critical metrics and insights around patient and resource allocation factors that shape a successful market entry. Meanwhile, the third is a pitfalls study that highlights the risk levels for stumbling over product, physician, patient and payer issues that affect a cardiovascular launch. The fourth new study examines how to optimize the activities of a professional and trade relations group and the last study presents an evaluation of the industry's use of exclusive vendor partnerships. The five new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.

If you would like to receive this monthly alert, sign-up here.
 
Newly Added Research
 
Click here to view abstracts for any of these new titles or paste the following link into your browser: http://www3.best-in-class.com/de1365.htm

Best Practice Database Documents

• Pitfalls to Avoid for a Strong Cardiovascular Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls (ID 5132)
• Patient Factors that Shape a Successful Cardiovascular Market Entry: Education and DTC Marketing (ID 5130)
• Resource Allocation and Launch Readiness Factors that Shape a Strong Cardiovascular Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions (ID 5131)
• Professional & Trade Relations Excellence: Optimizing Group Operations, Showing Value & Meeting Challenges (ID 5133)
• Market Research Vendor Management Excellence: Evaluating the Use of Exclusive Vendor Partnerships (ID 5135)

• Scientific Publication Strategy: Management of Reputation, Clinical Trial Results and Commercial Relevance